Risk Stratification in Acutely Admitted Medical Patients

Hematologic Tests Clinical Trial

Official title:

Risk Stratification in Acutely Admitted Medical Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00768547
• Other study ID #: risk stratification
• Status: Completed
• Phase: N/A
• First received: October 7, 2008
• Last updated: July 21, 2011
• Start date: August 2008
• Est. completion date: July 2011

Study information

• Verified date: August 2008
• Source: Ribe County Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Danish Dataprotection Agency
• Study type: Observational

Clinical Trial Summary

The study has three main parts.

1. To see if we can develop a riskstratification tool that can be used to asses the risk for acutely admitted medical patients for inhospital death, admission to the ICU and death within 30 days of release.

2. To test existing tool as in 1.

3. To clarify if it is most reasonable to let the admitting doctor order blood test by clinical judgment or be using a predefined list of tests.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5900
• Est. completion date: July 2011
• Est. primary completion date: July 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• Any patient acutely admitted to the medical department of Ribe County Hospital

Exclusion Criteria:

• Age below 15 years

• Unwilling to participate

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Hematologic Tests

Locations

Country	Name	City	State
Denmark	Ribe County Hospital	Esbjerg

Sponsors (1)

Lead Sponsor	Collaborator
Ribe County Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of test taken in each group		Five months	No